SMAD4 and pancreatic neoplasm: Another study demonstrated that SMAD4 mutation was associated with pancreatic tumor stages; the degree of inactivation was 31% in high-grade stage neoplasms (Pan IN-3), while none was found in the low-grade lesions (Pan IN-1-2) [187].